1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase

Biochemical and Biophysical Research Communications

Volumn 443, Issue 1, 2014, Pages 185-188

  Wilson, Jennifer C ^a   Laloo, Andrew Elohim ^b   Singh, Sanjesh ^a   Ferro, Vito ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Fondaparinux; Glycosidase mechanisms; Heparanase; NMR spectroscopy

Indexed keywords

FONDAPARINUX; GLYCOSIDASE; HEPARANASE; PENTASACCHARIDE; ANTINEOPLASTIC AGENT; BETA GLUCURONIDASE; ENZYME INHIBITOR; HEPARAN SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSACCHARIDE;

ANGIOGENESIS; ARTICLE; HUMAN; HYDROLYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SEQUENCE ANALYSIS; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DESIGN; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE; DRUG ANTAGONISM; GLYCOSIDASE MECHANISMS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; DRUG DESIGN; ENZYME INHIBITORS; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMANS; HYDROLYSIS; MOLECULAR TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POLYSACCHARIDES;

FONDAPARINUX; GLYCOSIDASE MECHANISMS; HEPARANASE; NMR SPECTROSCOPY;

EID: 84890856562     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.11.079     Document Type: Article

References (32)

1. Hulett M.D., Freeman C., Hamdorf B.J., Baker R.T., Harris M.J., Parish C.R. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 1999, 5:803-809.
2. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., Bitan M., Pappo O., Peretz T., Michal I., Spector L., Pecker I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 1999, 5:793-802.
3. Ilan N., Elkin M., Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 2006, 38:2018-2039.
4. Vlodavsky I., Beckhove P., Lerner I., Pisano C., Meirovitz A., Ilan N., Elkin M. Significance of heparanase in cancer and inflammation. Cancer Microenviron. 2012, 5:115-132.
5. Ferro V., Hammond E., Fairweather J.K. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini-Rev. Med. Chem. 2004, 4:693-702.
6. Hammond E., Bytheway I., Ferro V. Heparanase as a target for anticancer therapeutics: new developments and future prospects. New Developments in Therapeutic Glycomics 2006, 251-282. Research Signpost, Trivandrum, India. M. Delehedde, H. Lortat-Jacob (Eds.).
7. McKenzie E.A. Heparanase: a target for drug discovery in cancer and inflammation. Br. J. Pharmacol. 2007, 151:1-14.
8. Miao H.Q., Liu H., Navarro E., Kussie P., Zhu Z. Development of heparanase inhibitors for anti-cancer therapy. Curr. Med. Chem. 2006, 13:2101-2111.
9. Ferro V. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses. Expert Opin. Ther. Targets 2013, 17:965-975.
10. Ferro V., Liu L., Johnstone K.D., Wimmer N., Karoli T., Handley P., Rowley J., Dredge K., Li C.P., Hammond E., Davis K., Sarimaa L., Harenberg J., Bytheway I. Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J. Med. Chem. 2012, 55:3804-3813.
11. Johnstone K.D., Karoli T., Liu L., Dredge K., Copeman E., Li C.P., Davis K., Hammond E., Bytheway I., Kostewicz E., Chiu F.C., Shackleford D.M., Charman S.A., Charman W.N., Harenberg J., Gonda T.J., Ferro V. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth. J. Med. Chem. 2010, 53:1686-1699.
12. Naggi A., Casu B., Perez M., Torri G., Cassinelli G., Penco S., Pisano C., Giannini G., Ishai-Michaeli R., Vlodavsky I. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J. Biol. Chem. 2005, 280:12103-12113.
13. Parish C.R., Freeman C., Brown K.J., Francis D.J., Cowden W.B. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res. 1999, 59:3433-3441.
14. Zhou H., Roy S., Cochran E., Zouaoui R., Chu C.L., Duffner J., Zhao G., Smith S., Galcheva-Gargova Z., Karlgren J., Dussault N., Kwan R.Y., Moy E., Barnes M., Long A., Honan C., Qi Y.W., Shriver Z., Ganguly T., Schultes B., Venkataraman G., Kishimoto T.K. M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS ONE 2011, 6:e21106.
15. Peterson S.B., Liu J. Multi-faceted substrate specificity of heparanase. Matrix Biol. 2013, 32:223-227.
16. Peterson S.B., Liu J. Unraveling the specificity of heparanase utilizing synthetic substrates. J. Biol. Chem. 2010, 285:14504-14513.
17. Peterson S., Liu J. Deciphering mode of action of heparanase using structurally defined oligosaccharides. J. Biol. Chem. 2012, 287:34836-34843.
18. http://www.cazy.org/GH79.html.
19. Hulett M.D., Hornby J.R., Ohms S.J., Zuegg J., Freeman C., Gready J.E., Parish C.R. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 2000, 39:15659-15667.
20. Fux L., Feibish N., Cohen-Kaplan V., Gingis-Velitski S., Feld S., Geffen C., Vlodavsky I., Ilan N. Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling. Cancer Res. 2009, 69:1758-1767.
21. Gandhi N.S., Freeman C., Parish C.R., Mancera R.L. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-beta-d-glucuronidase (heparanase). Glycobiology 2012, 22:35-55.
22. Sapay N., Cabannes E., Petitou M., Imberty A. Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids. Biopolymers 2012, 97:21-34.
23. Zechel D.L., Withers S.G. Glycosidase mechanisms: anatomy of a finely tuned catalyst. Acc. Chem. Res. 2000, 33:11-18.
24. 1H N.M.R. determination of the stereochemical course of hydrolyses catalysed by glucanase components of the cellulase complex. Biochem. Biophys. Res. Commun. 1986, 139:487-494.
25. 1H NMR evidence that salmonella typhimurium sialidase hydrolyzes sialosides with overall retention of configuration. J. Am. Chem. Soc. 1995, 117:4214-4217.
26. Bisio A., Mantegazza A., Urso E., Naggi A., Torri G., Viskov C., Casu B. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase. Semin. Thromb. Hemost. 2007, 33:488-495.
27. Hammond E., Li C.P., Ferro V. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening. Anal. Biochem. 2010, 396:112-116.
28. Hammond E., Handley P., Dredge K., Bytheway I. Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues. FEBS Open Bio 2013, 3:346-351.
29. Pearson A.G., Kiefel M.J., Ferro V., von Itzstein M. Synthesis of simple heparanase substrates. Org. Biomol. Chem. 2011, 9:4614-4625.
30. McKenzie E., Young K., Hircock M., Bennett J., Bhaman M., Felix R., Turner P., Stamps A., McMillan D., Saville G., Ng S., Mason S., Snell D., Schofield D., Gong H., Townsend R., Gallagher J., Page M., Parekh R., Stubberfield C. Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochem. J. 2003, 373:423-435.
31. Davis T.R., Trotter K.M., Granados R.R., Wood H.A. Baculovirus expression of alkaline phosphatase as a reporter gene for evaluation of production, glycosylation and secretion. Biotechnology (N Y) 1992, 10:1148-1150.
32. 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. Biochem. Biophys. Res. Commun. 1985, 128:134-140.